Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery
Authors:
Top Cited Papers
- 1 January 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 108 (1) , 194-195
Abstract
Human parvovirus B19 infection has been shown to be transmissible by blood and blood products and to result in transient aplastic crisis in patients with rapid red cell turnover. We report three cases of iatrogenic parvovirus B19 infection resulting from the use of the same batch of fibrin sealant under operation. Fibrin sealant, which is a typical haemostatic agent produced from blood, has been used during surgery. Human parvovirus is resistant to existing virus‐inactivating techniques, suggesting that infection may occur from blood products contaminated with it. Use of recombinant products for these proteins may thus be necessary.Keywords
This publication has 9 references indexed in Scilit:
- Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufactureBritish Journal of Haematology, 1996
- A Randomised Trial of Fibrin Sealant in Peripheral Vascular SurgeryVox Sanguinis, 1996
- Incidence of human parvovirus B19 DNA detection in blood donorsBritish Journal of Haematology, 1995
- Erythrocyte P Antigen: Cellular Receptor for B19 ParvovirusScience, 1993
- Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reactionBritish Journal of Haematology, 1992
- Detection of parvovirus B19 by dot-blot and polymerase chain reactionMolecular and Cellular Probes, 1990
- Human ParvovirusesThe Journal of Infectious Diseases, 1990
- Febrile illness due to a parvovirus.BMJ, 1980
- PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 1975